Mayur Ian Somaiya, Chief Financial Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 5,118 shares at $33.25 ($170K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $170k NAMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TCRR | SELL | 2020-11-19 | $110K | — | Filing → |